Free Trial

Guardian Pharmacy Services (GRDN) Competitors

Guardian Pharmacy Services logo
$22.13 -0.41 (-1.82%)
(As of 05:27 PM ET)

GRDN vs. PETS, YI, CJJD, CVS, WBA, TLX, TGTX, VKTX, BBIO, and GRFS

Should you be buying Guardian Pharmacy Services stock or one of its competitors? The main competitors of Guardian Pharmacy Services include PetMed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD), CVS Health (CVS), Walgreens Boots Alliance (WBA), Telix Pharmaceuticals Limited American Depositary Shares (TLX), TG Therapeutics (TGTX), Viking Therapeutics (VKTX), BridgeBio Pharma (BBIO), and Grifols (GRFS).

Guardian Pharmacy Services vs.

PetMed Express (NASDAQ:PETS) and Guardian Pharmacy Services (NYSE:GRDN) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, community ranking, risk, media sentiment, valuation, dividends and profitability.

PetMed Express received 211 more outperform votes than Guardian Pharmacy Services when rated by MarketBeat users. However, 100.00% of users gave Guardian Pharmacy Services an outperform vote while only 45.17% of users gave PetMed Express an outperform vote.

CompanyUnderperformOutperform
PetMed ExpressOutperform Votes
215
45.17%
Underperform Votes
261
54.83%
Guardian Pharmacy ServicesOutperform Votes
4
100.00%
Underperform Votes
No Votes

In the previous week, Guardian Pharmacy Services had 2 more articles in the media than PetMed Express. MarketBeat recorded 3 mentions for Guardian Pharmacy Services and 1 mentions for PetMed Express. PetMed Express' average media sentiment score of 1.31 beat Guardian Pharmacy Services' score of 1.10 indicating that PetMed Express is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PetMed Express
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Guardian Pharmacy Services
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PetMed Express currently has a consensus target price of $3.50, suggesting a potential downside of 37.28%. Guardian Pharmacy Services has a consensus target price of $22.00, suggesting a potential downside of 0.86%. Given Guardian Pharmacy Services' stronger consensus rating and higher possible upside, analysts clearly believe Guardian Pharmacy Services is more favorable than PetMed Express.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetMed Express
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Guardian Pharmacy Services
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

73.3% of PetMed Express shares are owned by institutional investors. 1.1% of PetMed Express shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Guardian Pharmacy Services has a net margin of 0.00% compared to PetMed Express' net margin of -0.37%. Guardian Pharmacy Services' return on equity of 0.00% beat PetMed Express' return on equity.

Company Net Margins Return on Equity Return on Assets
PetMed Express-0.37% -1.00% -0.60%
Guardian Pharmacy Services N/A N/A N/A

Guardian Pharmacy Services has higher revenue and earnings than PetMed Express.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PetMed Express$281.06M0.41-$7.46M-$0.06-93.00
Guardian Pharmacy Services$1.17B1.20N/AN/AN/A

Summary

Guardian Pharmacy Services beats PetMed Express on 10 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRDN vs. The Competition

MetricGuardian Pharmacy ServicesDrug stores & proprietary stores IndustryMedical SectorNYSE Exchange
Market Cap$1.40B$7.56B$5.14B$19.68B
Dividend YieldN/A7.50%4.83%3.51%
P/E RatioN/A2.24133.4843.82
Price / Sales1.200.281,159.6617.71
Price / CashN/A82.6140.5621.73
Price / BookN/A0.804.885.45
Net IncomeN/A-$46.88M$118.62M$987.88M
7 Day Performance-7.08%-4.02%14.34%-2.21%
1 Month Performance3.98%4.71%14.69%0.76%
1 Year PerformanceN/A-42.97%34.16%16.46%

Guardian Pharmacy Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GRDN
Guardian Pharmacy Services
0.5611 of 5 stars
$22.13
-1.8%
$22.00
-0.6%
N/A$1.40B$1.17B0.003,200Positive News
PETS
PetMed Express
0.9254 of 5 stars
$5.46
-0.9%
$3.50
-35.9%
-23.9%$112.80M$281.06M0.00287Positive News
YI
111
0.5542 of 5 stars
$0.79
-4.9%
N/A-48.1%$67.57M$2.11B-2.081,520
CJJD
China Jo-Jo Drugstores
N/A$1.88
+1.8%
N/A-58.3%$12.53M$154.54M0.00980Analyst Forecast
Short Interest ↓
News Coverage
Gap Up
CVS
CVS Health
5 of 5 stars
$46.62
-5.6%
$70.50
+51.2%
-40.8%$58.67B$368.91B12.53300,000
WBA
Walgreens Boots Alliance
4.1819 of 5 stars
$10.10
-2.8%
$12.58
+24.5%
-60.4%$8.73B$147.66B-1.04312,000
TLX
Telix Pharmaceuticals Limited American Depositary Shares
N/A$16.68
+5.8%
$21.00
+25.9%
N/A$5.58BN/A0.00N/ANews Coverage
Positive News
TGTX
TG Therapeutics
4.3559 of 5 stars
$34.10
+6.5%
$40.67
+19.3%
+81.7%$5.31B$233.66M-320.17290Positive News
VKTX
Viking Therapeutics
4.2948 of 5 stars
$47.15
+0.3%
$106.75
+126.4%
+147.1%$5.25BN/A-51.5620Analyst Forecast
Gap Down
BBIO
BridgeBio Pharma
4.7106 of 5 stars
$27.72
+0.8%
$47.69
+72.1%
-29.3%$5.24B$217.77M-11.63400Analyst Forecast
GRFS
Grifols
3.4884 of 5 stars
$7.56
+3.1%
N/A-21.6%$5.20B$7.01B0.0023,737Gap Down

Related Companies and Tools


This page (NYSE:GRDN) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners